Xilio Therapeutics Inc (NAS:XLO)
$ 1.12 -0.06 (-5.08%) Market Cap: 41.34 Mil Enterprise Value: 11.36 Mil PE Ratio: 0 PB Ratio: 0.84 GF Score: 21/100

Xilio Therapeutics Inc (XLO) Stock Estimates Data

Xilio Therapeutics Inc (XLO) 12 Month Price Targets

Xilio Therapeutics Inc (XLO) Analyst Rating